Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesPayablesPreferred SharesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Us Nuclear (UCLE) Shares Outstanding (2016 - 2025)

Us Nuclear (UCLE) has disclosed Shares Outstanding for 11 consecutive years, with $61.4 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding rose 3268391.11% to $61.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $61.4 million through Sep 2025, up 3268391.11% year-over-year, with the annual reading at $52.7 million for FY2024, 31.21% up from the prior year.
  • Shares Outstanding hit $61.4 million in Q3 2025 for Us Nuclear, up from $59.9 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $61.4 million in Q3 2025 to a low of $1878.0 in Q3 2024.
  • Historically, Shares Outstanding has averaged $37.1 million across 5 years, with a median of $34.6 million in 2023.
  • Biggest YoY gain for Shares Outstanding was 3268391.11% in 2025; the steepest drop was 100.0% in 2025.
  • Year by year, Shares Outstanding stood at $28.4 million in 2021, then rose by 11.53% to $31.6 million in 2022, then rose by 27.05% to $40.2 million in 2023, then skyrocketed by 31.21% to $52.7 million in 2024, then increased by 16.45% to $61.4 million in 2025.
  • Business Quant data shows Shares Outstanding for UCLE at $61.4 million in Q3 2025, $2006.0 in Q2 2025, and $2006.0 in Q1 2025.